After being at the helm for over a decade of internet juggernaut Google, former CEO Eric Schmidt has switched gears and one of his latest activities is being an advocate for the fast-growing US bioeconomy, which is valued at over $1T. During his keynote at the 2022 SynBioBeta conference in Oakland, CA last year, he passed along advice for the next generation of biotechnologists, detailing what is needed from different stakeholders to fulfill the potential of the global bioeconomy to solve the world’s biggest problems. I caught up with Schmidt again recently, a year since his talk, to see what progress has been made. You can see the full Q&A here.
I think it’s time.
Comments are closed.